Proposal to calculate combined effects of chemicals in the environment at EU level Current legislation for chemicals insufficiently covers the combined effects of substances on humans and the environment.
Ebola information for GPs RIVM has sent a message to Community Health Services (GGD's) containing information about how issues concerning Ebola are arranged in the Netherlands.
Possibly more cases of gastroenteritis caused by antacids In recent years the Netherlands has witnessed an increase in the number of cases of gastroenteritis caused by the Campylobacter bacterium.
Annual report RIVM 2013 online In our annual report, we look back at compelling RIVM projects and research in 2013.
Ongoing Ebola outbreak West Africa August 8th the World Health Organization declared the Ebola outbreak in West Africa an international health emergency and appealed for global aid to help afflicted countries.
Mental care still the most expensive of all In 2011, 19.6 billion euros was spent on the treatment of mental disorders. This amounted to 22% of the total expenditure on health and welfare during that year.
Risks of eHealth technology RIVM and Nictiz have made an overview of the risks that eHealth applications may entail and how these risks can be controlled.
Key organisations unite to improve benefit and risk assessments of vaccines Leading organisations have joined forces to launch a unique project that will pave the way for a pan-European framework for rapidly assessing and communicating the benefits and risks of vaccines.
Human and veterinary health sectors join forces for responsible use of antibiotics. Bacteria that are resistant to almost all antibiotics continue to spread across Europe. This was revealed by new figures from the European Centre for Disease Prevention and Control (ECDC).
In The Spotlight: Young Researchers RIVM 'Young Researchers' present their PhD research in 4 short films which were made especially to highlight and explain their scientific research.